The Global Asthma Report 2018

Maps, Data, and Resources

1. Global Asthma Network
Figure. Global Asthma Network centres at June 2018.
2. About Asthma
Table. Prevalence of asthma symptoms among 13-14 year olds (ISAAC).
3. Global Burden of Disease due to Asthma
Figure 1. Prevalence of asthma symptoms among 13-14 year olds (ISAAC).
Figure 2. Prevalence of severe asthma among 13-14 year olds (ISAAC).
Figure 3. Prevalence of symptoms of asthma in the past 12 months among persons aged 18 to 45 years in 70 countries, World Health Survey 2002-2003.
Figure 4. Burden of disease, measured by disability adjusted life years (DALYs) per 100,000 population attributed to asthma by age group and sex 2010.
4. Hospital Admissions for Asthma 
Figure 1. Age-standardised admission rates for asthma for earliest and latest available year in European countries ordered by latest admission rate.
Figure 2. Asthma admission rates for European countries, age 5-14 v 20-44 years.
Figure 3. Long-term time trends in self-reported asthma prevalence, hospital admission rates and mortality rates for asthma among children in high-income countries.
Figure 4. Annual change in hospital admission rates for childhood asthma (ages 5-14) by change in prevalence of nocturnal wheezing among 13-14-year-olds in countries with one or more ISAAC centres providing prevalence data for both ISAAC Phase One (around 1995) and ISAAC Phase Three (around 2002).
5. Asthma Mortality
Figure 1. Age-standardised asthma mortality rates (all ages) 2001-2005 and 2011-2015 by country, ranked by 2011-2015 age-standardised mortality rate within World Bank 2014 income group.
Figure 2. Age-standardised asthma mortality rates (ages 5-34) 2001-2005 and 2011-2015 by country, ranked by 2011-2015 age-standardised mortality rate within World Bank 2014.
Figure 3. Relative changes in age standardised mortality and hospitalisation rates for asthma (all ages) in 24 European countries, 2011-2015 vs 2001-2005.
6.  The Economic Burden of Asthma
Figure. Success of a national asthma strategy: overall annual costs of asthma care at the societal level in Finland from 1987 to 2013; the national Asthma Program began in 1994. Monetary values are in euros (€).
7.  Factors Affecting Asthma
Figure. Effects of individual-level exposures on wheeze in the last 12 months. Mixed logistic regression models with random intercepts at the school, centre and country levels.
9. Spacers for Asthma and Wheezing in Children
Figure 1. Child using a homemade bottle spacer by holding the neck of the bottle in their mouth.
Figure 2. Mother using a homemade bottle spacer to give bronchodilator therapy to her infant.
10. Achieving Access to Affordable, Quality-Assured, Essential Asthma Medicines
Table. Measures needed to improve access to affordable quality-assured essential asthma medicines.
11. Asthma Management in Low-Income Countries.
Table. Standard Case Management: The eight components.
Figure. Example of financial mechanism to maintain supply and reduce cost.
12. Asthma in regions: Country reports from Africa.
Nigeria
Figure. Cover page of the Guideline for Asthma Management in Nigeria.
South Africa
Table. Prevalence of current symptoms of asthma (12 month prevalence rate of wheeze) by centre in South Africa in 6 – 7 year and 13 – 14 year age groups as measured on the International Study of Asthma and Allergies in Childhood (ISAAC) Phases One and Three.
13. Asthma in regions: Country reports from Asia and India.
China
Figure. Prevalence of asthma (asthma symptoms in the past 2 years) in children under 14 years from 43 major cities across China in 2010.
Indonesia
Table. Epidemiology studies on childhood asthma in Indonesia (2008–17).
14. Asthma in regions: Country reports from Latin America.
Argentina
Figure. Trends in asthma mortality in Argentina (1980-2015)Age- and sex-adjusted rates, crude rate and number of deaths
Tables and Figures in appendices 
Table. Prevalence of current symptoms of asthma by world region in 6 – 7 year and 13 – 14 year age groups as measured in the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three.

Next: Glossary >

The global epidemic of NCDs is a major and growing challenge to development.